GRTX galeratx.com: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan

Tandha merek Galera Therapeutics (GRTX)

The quote characteristics for Galera Therapeutics (GRTX) on GURU.Markets based on the separate_ev_ebitda metric are . Galera Therapeutics (GRTX) is implementing digital systems for remote monitoring of trial participants to eliminate manual data entry. The firm previously developed radiation protection agents based on mimetics. Currently, due to FDA prohibitions, the company is shutting down development and distributing remaining cash funds to shareholders.

GRTX Galera Therapeutics Inc.: Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan ing interval 04.07.2022 - 15.11.2026

Rincian metrik lan analitis perusahaan Galera (GRTX)

- rega saham lan target rega konsensus:
Kutipan saham Galera Therapeutics, Inc.|GRTX - Rata-rata rega prakiraan
- data kapitalisasi saham perusahaan:
Biji pasar Galera Therapeutics Inc.|GRTX - Nilai Dipunlarasaken Utang lan Kas
- rincian valuasi buku bisnis:
Aset Bersih saben Siji Saham Galera Therapeutics|GRTX - Nilai Aset Bersih|Rasio Nilai Pasar marang Nilai Buku galeratx.com|GRTX - Aset Agregat Perusahaan
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Galera Therapeutics|GRTX - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Galera Therapeutics, Inc.|GRTX - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Galera Therapeutics|GRTX - Kewajiban jangka dawa|Utang jangka cendhak perusahaan Galera Therapeutics|Likuiditas cepet galeratx.com
- data bathi bisnis lan rasio investasi:
GRTX - Bathi pungkasan|Bathi sing dikarepake Galera Therapeutics|GRTX - Koefisien rega marang bathi|Rega marang bathi mangsa ngarep galeratx.com|GRTX - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Galera Therapeutics, Inc.|GRTX - Bathi operasional sadurunge potongan amortisasi|Bathi resik saben saham (EPS TTM) Galera Therapeutics|GRTX - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan galeratx.com|GRTX - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Galera Therapeutics
- informasi babagan volume dodolan lan pendapatan:
GRTX - Total pendapatan perusahaan|Prakiraan pendapatan perusahaan Galera Therapeutics|GRTX - Rasio kapitalisasi pasar marang pendapatan|Multiplikator Forward P/S Galera Therapeutics|GRTX - Wutah dodolan YoY (TTM)
Analisis umum perusahaan:Galera Therapeutics GRTX
Sampel barang Galera Therapeutics Inc.

Galera Therapeutics (GRTX) is in a critical state due to failed clinical trials and a loss of confidence in management. This indicator compares the total enterprise value, including debt, with its operating profit, revealing the asset's real value regardless of financial manipulations. By analyzing the Galera Therapeutics (GRTX) EV/EBITDA multiple chart, investors determine whether the current low valuation is a sign of undervaluation or a precursor to the biotech's imminent bankruptcy.

Pesaing langsung

Geron Corp - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nanobiotix (NBTX) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|BCYC: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai bisnis marang bathi operasional sadurunge panyusutan CTMX (CytomX Pharma)|Perspective Therapeutics, Inc. (CATX) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan GNLX (Genelux Corp)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Molecular Partners|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ONCY|Pangali EV/EBITDA LSTA|Pangali EV/EBITDA Moleculin (MBRX)|Molecular Templates, Inc. - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan